- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MET- ILE- ILE- MET: MET-ILE-ILE-MET(Non-covalent)
- 23 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 5 residues within 4Å:- Chain A: L.109, N.113, R.129, S.143, E.144
Ligand excluded by PLIPEDO.3: 6 residues within 4Å:- Chain A: H.240, V.242, V.301, P.302, L.303
- Ligands: EDO.4
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: V.242, P.302, D.333, R.336
- Chain B: E.307
- Ligands: EDO.3, EDO.22
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: Y.88, W.91, Q.124, H.127, H.128
- Chain B: C.189, E.193
Ligand excluded by PLIPEDO.6: 8 residues within 4Å:- Chain A: R.195, V.196, D.197, G.198, L.237, I.238
- Chain B: R.22, P.23
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: I.178, W.183, G.216
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: R.211, E.218, S.223, L.224, E.227, F.255
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: R.26, W.29, R.72, E.75, I.79
Ligand excluded by PLIPEDO.16: 9 residues within 4Å:- Chain B: D.210, I.211, I.212, W.457, A.466, R.467, I.470, Y.516
- Ligands: EDO.20
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain A: H.127, L.130
- Chain B: R.181, E.193, V.194
- Ligands: EDO.23
Ligand excluded by PLIPEDO.18: 3 residues within 4Å:- Chain B: A.105, K.111, R.507
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain B: G.103, V.104, A.105
Ligand excluded by PLIPEDO.20: 7 residues within 4Å:- Chain B: D.210, I.212, A.447, V.448, R.463, R.467
- Ligands: EDO.16
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain B: M.425, W.477, T.496, T.497, T.498, L.504, G.505
Ligand excluded by PLIPEDO.22: 8 residues within 4Å:- Chain A: R.336
- Chain B: L.303, Q.304, Q.305, G.306, E.307, R.315
- Ligands: EDO.4
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: L.130, A.163, W.167
- Chain B: M.262
- Ligands: EDO.17
Ligand excluded by PLIPEDO.24: 9 residues within 4Å:- Chain A: Q.37, Y.49, M.57, R.61
- Chain B: D.85, G.131, P.132, S.135, Q.136
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain B: A.441, K.443, G.444, L.445, R.463, Q.464, R.467
Ligand excluded by PLIPEDO.26: 5 residues within 4Å:- Chain B: A.166, A.167, R.169, Q.170, P.446
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain B: Q.390, R.405, P.406
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain B: R.178, C.179, K.180, R.181, V.187
Ligand excluded by PLIPEDO.29: 5 residues within 4Å:- Chain B: P.124, K.125, Q.170, S.171, E.174
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: I.292, D.293, A.294, N.295, E.344
Ligand excluded by PLIP- 1 x ZN: ZINC ION(Non-covalent)
- 3 x 3FX: (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid(Non-covalent)
3FX.11: 4 residues within 4Å:- Chain B: Y.58, G.489, K.490, D.491
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:K.490, B:D.491, B:D.491, B:D.491
- Water bridges: B:Y.58, B:N.492
3FX.12: 4 residues within 4Å:- Chain B: R.62, K.63, Q.64, E.65
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.62, B:Q.64, B:E.65
- Water bridges: B:K.63, B:K.63
3FX.13: 10 residues within 4Å:- Chain A: A.64, T.89
- Chain B: S.123, P.124, K.125, A.133, N.134, S.135, Q.136, I.137
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:I.137, A:A.64, A:T.89
- Hydrogen bonds: B:K.125
- 1 x FII: [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID(Non-covalent)
FII.14: 17 residues within 4Å:- Chain A: Y.123, Y.159
- Chain B: L.141, R.197, Y.200, C.201, H.266, G.268, Y.269, C.272, R.317, K.320, Y.326, W.329, Y.409
- Ligands: MET-ILE-ILE-MET.1, BT6.15
14 PLIP interactions:12 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:L.141, B:R.197, B:Y.200, B:Y.269, B:W.329, B:W.329, A:Y.159
- Hydrogen bonds: B:R.317, B:K.320, B:Y.326, B:Y.326
- Water bridges: B:R.317, B:K.320, A:Y.159
- 1 x BT6: benzenethiol(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Y. et al., Cryptococcus neoformans protein farnesyltransferase in complex with FPTII and TKCMIIM peptide. To Be Published
- Release Date
- 2023-08-09
- Peptides
- Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha: A
Protein farnesyltransferase subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MET- ILE- ILE- MET: MET-ILE-ILE-MET(Non-covalent)
- 23 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x ZN: ZINC ION(Non-covalent)
- 3 x 3FX: (2R)-3-(cyclohexylamino)-2-hydroxypropane-1-sulfonic acid(Non-covalent)
- 1 x FII: [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID(Non-covalent)
- 1 x BT6: benzenethiol(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, Y. et al., Cryptococcus neoformans protein farnesyltransferase in complex with FPTII and TKCMIIM peptide. To Be Published
- Release Date
- 2023-08-09
- Peptides
- Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha: A
Protein farnesyltransferase subunit beta: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B